Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
50%(2 trials)

Phase Distribution

Ph not_applicable
3
33%
Ph phase_3
4
44%
Ph phase_4
1
11%

Phase Distribution

0

Early Stage

0

Mid Stage

5

Late Stage

Phase Distribution8 total trials
Phase 3Large-scale testing
4(50.0%)
Phase 4Post-market surveillance
1(12.5%)
N/ANon-phased studies
3(37.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Completed(4)
Other(5)

Detailed Status

unknown5
Completed4

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 34 (50.0%)
Phase 41 (12.5%)
N/A3 (37.5%)

Trials by Status

completed444%
unknown556%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
DRUG
Total Trials
9